A Phase II Trial of Poly-ICLC for Low-Grade Gliomas
Condition(s):NF1; Low-grade GliomaLast Updated:October 22, 2020Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):NF1; Low-grade GliomaLast Updated:October 22, 2020Not yet recruiting
Condition(s):Glioblastoma Multiforme; Glioblastoma, Adult; Glioma of Brain; Glioblastoma Multiforme of BrainLast Updated:December 11, 2020Recruiting
Condition(s):Melanoma; Head and Neck Cancer; Sarcoma; Non-Melanoma Skin CancersLast Updated:December 17, 2020Completed
Condition(s):HIV-1 Infected Adults With Chronic HIV-1 InfectionLast Updated:March 13, 2018Completed
Condition(s):Metastatic Colon Cancer; Solid TumorLast Updated:June 17, 2020Recruiting
Condition(s):Melanoma; Squamous Cell Carcinoma of the Head and Neck; Squamous Cell Carcinoma of the Skin; Sarcoma of the Skin; Basal Cell Cancer of the Skin; Breast CancerLast Updated:January 23, 2018Terminated
Condition(s):Solid CancerLast Updated:February 1, 2021Terminated
Condition(s):Glioma; Malignant Glioma; Astrocytoma, Grade II; Oligodendroglioma; Glioma, Astrocytic; Oligoastrocytoma, MixedLast Updated:June 12, 2020Recruiting
Condition(s):CNS Tumor, AdultLast Updated:April 20, 2016Completed
Condition(s):Healthy VolunteersLast Updated:August 13, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.